Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$94.2M Sell
237,200
-162,377
-41% -$46.2M 0.02% 519
2026
Q1
$69.3M Buy
399,577
+45,998
+13% +$9.43M 0.02% 623
2025
Q4
$90.6M Sell
353,579
-53,830
-13% -$14.1M 0.02% 539
2025
Q3
$106M Buy
407,409
+102,092
+33% +$26.8M 0.02% 473
2025
Q2
$74.6M Buy
305,317
+15,807
+5% +$3.94M 0.02% 575
2025
Q1
$76.6M Sell
289,510
-6,889
-2% -$1.86M 0.02% 509
2024
Q4
$75.2M Sell
296,399
-60,573
-17% -$16.2M 0.02% 510
2024
Q3
$113M Buy
356,972
+37,934
+12% +$13.5M 0.03% 393
2024
Q2
$119M Sell
319,038
-35,342
-10% -$11.9M 0.04% 336
2024
Q1
$123M Sell
354,380
-1,083
-0.3% -$410K 0.04% 336
2023
Q4
$163M Buy
355,463
+60,333
+20% +$29.7M 0.06% 280
2023
Q3
$144M Sell
295,130
-66,679
-18% -$31.3M 0.09% 220
2023
Q2
$162M Buy
361,809
+185,399
+105% +$93.3M 0.1% 180
2023
Q1
$85.6M Sell
176,410
-72,885
-29% -$36M 0.04% 291
2022
Q4
$128M Buy
249,295
+58,863
+31% +$30.9M 0.06% 226
2022
Q3
$92.4M Buy
190,432
+87,062
+84% +$42.3M 0.1% 191
2022
Q2
$48.4M Sell
103,370
-86,944
-46% -$38.7M 0.03% 410
2022
Q1
$82.8M Sell
190,314
-37,039
-16% -$15.5M 0.06% 283
2021
Q4
$105M Sell
227,353
-36,759
-14% -$16.3M 0.04% 331
2021
Q3
$103M Buy
264,112
+65,024
+33% +$27.6M 0.05% 312
2021
Q2
$88.1M Buy
199,088
+36,774
+23% +$16.1M 0.04% 328
2021
Q1
$68M Buy
162,314
+17,143
+12% +$6.84M 0.04% 357
2020
Q4
$59.6M Sell
145,171
-342
-0.2% -$142K 0.03% 402
2020
Q3
$60.2M Buy
145,513
+26,509
+22% +$10.7M 0.04% 353
2020
Q2
$46.1M Sell
119,004
-4,227
-3% -$1.58M 0.04% 355
2020
Q1
$38.7M Sell
123,231
-95,062
-44% -$32.1M 0.03% 389
2019
Q4
$80M Sell
218,293
-5,467
-2% -$1.73M 0.04% 327
2019
Q3
$57.2M Buy
223,760
+7,608
+4% +$2.13M 0.04% 412
2019
Q2
$57.3M Sell
216,152
-175,659
-45% -$44.5M 0.04% 446
2019
Q1
$104M Buy
391,811
+186,232
+91% +$53.7M 0.07% 216
2018
Q4
$58.9M Sell
205,579
-39,323
-16% -$12.5M 0.05% 325
2018
Q3
$82.9M Sell
244,902
-37,822
-13% -$12.3M 0.06% 258
2018
Q2
$84.1M Sell
282,724
-77,612
-22% -$22.7M 0.07% 228
2018
Q1
$96.9M Buy
360,336
+116,340
+48% +$31.5M 0.07% 221
2017
Q4
$60.5M Buy
243,996
+71,443
+41% +$17.6M 0.05% 327
2017
Q3
$42M Buy
172,553
+15,228
+10% +$3.73M 0.04% 362
2017
Q2
$37.9M Sell
157,325
-547,741
-78% -$124M 0.04% 368
2017
Q1
$145M Buy
705,066
+344,598
+96% +$71.2M 0.16% 95
2016
Q4
$73.5M Sell
360,468
-132,782
-27% -$25.3M 0.08% 195
2016
Q3
$87.3M Buy
493,250
+346,391
+236% +$60.1M 0.1% 156
2016
Q2
$26.4M Sell
146,859
-35,473
-19% -$6.3M 0.03% 411
2016
Q1
$33.2M Buy
182,332
+24,993
+16% +$4.34M 0.05% 330
2015
Q4
$28M Buy
157,339
+31,594
+25% +$5.54M 0.03% 450
2015
Q3
$22.5M Sell
125,745
-356,974
-74% -$66M 0.03% 552
2015
Q2
$92.2M Buy
482,719
+383,726
+388% +$71.2M 0.1% 160
2015
Q1
$17.6M Sell
98,993
-169,452
-63% -$26.8M 0.02% 755
2014
Q4
$38.4M Sell
268,445
-73,079
-21% -$9.98M 0.04% 448
2014
Q3
$44.4M Buy
341,524
+38,409
+13% +$4.88M 0.04% 366
2014
Q2
$38.5M Sell
303,115
-268,613
-47% -$31.8M 0.04% 398
2014
Q1
$64M Buy
571,728
+280,051
+96% +$29.2M 0.07% 237
2013
Q4
$30M Buy
291,677
+129,769
+80% +$12.7M 0.03% 546
2013
Q3
$15.1M Sell
161,908
-181,743
-53% -$16.7M 0.02% 849
2013
Q2
$29M Buy
+343,651
New +$27.1M 0.04% 456

Other funds holding HUM

Barclays's HUM Position: Q2 2026 in Review

Barclays reduced its Humana (HUM) stake by 41% in Q2 2026, selling an estimated $46.2M and leaving 237,200 shares worth $94.2M. The position accounts for 0.02% of the portfolio, ranked #519.

Barclays first reported a position in HUM in Q2 2013 and has held it in 53 quarters since. The position peaked at $163M in Q4 2023. 923 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Barclays held 237,200 shares of Humana worth $94.2M as of Q2 2026.
  • Barclays sold 162,377 Humana shares in Q2 2026, an estimated $46.2M.
  • Humana made up 0.02% of Barclays's portfolio in Q2 2026, its #519 holding.
  • Barclays first reported a position in Humana in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Humana position peaked at $163M in Q4 2023.
  • 923 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.